Effectiveness of a new bioequivalent formulation of oseltamivir (Enfluvir (R)) on 2010-2011 seasonal influenza viruses: an open phase IV study


CEYHAN M., Oncel E. K., Badur S., Ciblak M. A., Alhan E., Celik U. S., ...Daha Fazla

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.16, sa.4, 2012 (SCI-Expanded) identifier identifier identifier

Özet

Objective: The aim of this multicenter prospective study was to evaluate the efficacy of a new bioequivalent formulation of oseltamivir for the treatment of influenza A, influenza B, and H1N1 during the 2010-2011 influenza season.